Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Nevilledog

(51,031 posts)
Sun Nov 22, 2020, 12:23 AM Nov 2020

Experimental drug given to Trump to treat covid-19 wins FDA clearance



Tweet text:
John FitzGerald
@TheTweetOfJohn
The shortages, coupled with the complexities of administering the intravenous medication, have raised concerns about whether people with the greatest need will be able to get it.

Experimental drug given to Trump to treat covid-19 wins FDA clearance
But Regeneron’s antibody treatment is expected to be in short supply.
washingtonpost.com


https://www.washingtonpost.com/health/2020/11/21/regeneron-fda-clearance/

The Food and Drug Administration on Saturday granted emergency authorization to the experimental antibody treatment given to President Trump last month when he developed covid-19, the disease caused by the novel coronavirus.

The drug, made by Regeneron Pharmaceuticals, is designed to prevent infected people from developing severe illness. Instead of waiting for the body to develop its own protective immune response, the drug imitates the body’s natural defenses. It is the second drug of this type — called a monoclonal antibody — to be cleared for treating covid-19. The FDA authorized Eli Lilly & Co.’s drug on Nov. 9.

Regeneron’s drug is a cocktail of two monoclonal antibodies, called casirivimab and imdevimab. The FDA said in authorizing the cocktail that it may be effective in treating mild to moderate covid-19 in adults and children 12 or older, and is indicated for those at high risk of developing severe illness. Doctors hope the drugs will keep those patients from being hospitalized.

But as with the Lilly treatment, the Regeneron drug is a biological product that is complicated and time-consuming to make; initially, it will be in short supply. The shortages, coupled with the complexities of administering the intravenous medication, have raised concerns about whether people with the greatest need will be able to get it.

Regeneron executives said on the company’s earnings call in early November that they project having enough doses for 80,000 patients by the end of November, and 300,000 total doses by the end of January.

*snip*




5 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Experimental drug given to Trump to treat covid-19 wins FDA clearance (Original Post) Nevilledog Nov 2020 OP
Did ben Carson take this? soothsayer Nov 2020 #1
I believe so, plus he says he took the MyPillow douche's Oleandrin Nevilledog Nov 2020 #2
Oh yeah i forgot about the my pillow cure soothsayer Nov 2020 #3
Yes he did take it and credits it for saving his life. Poiuyt Nov 2020 #4
I wonder if right wingers will be okay with using stem cells now that they saved their god's life? Poiuyt Nov 2020 #5
Latest Discussions»General Discussion»Experimental drug given t...